RLM Realm Thera.

TIDMPURI

RNS Number : 3073V

PuriCore Plc

10 January 2013

10 January 2013

PuriCore plc

("PuriCore" or the "Company")

PuriCore plc

Result of General Meeting

PuriCore (LSE: PURI), the water-based, clean technology company, announces that the special resolution proposed to the Company's shareholders at the General Meeting held earlier today was duly passed. Proxy figures will be displayed shortly on the Company's investor website at http://investor.puricore.com.

A copy of the resolution will be available shortly for inspection at the National Storage Mechanism at www.hemscott.com/nsm.do.

Application has been made for 24,786,601 New Ordinary Shares to be admitted to the Official List of the UK Listing Authority and to trading on the main market for listed securities of the London Stock Exchange plc, respectively. Dealings in the New Ordinary Shares are expected to commence at 8:00a.m. on 11 January 2013.

About PuriCore

PuriCore plc (LSE: PURI) is a water-based clean technology company focused on developing and commercialising proprietary solutions that protect people from the spread of infectious pathogens without causing harm to human health or the environment. The Company's products are used in a broad range of markets that depend upon effective pathogen control including MRSA, e.Coli, and C. difficile. PuriCore is a leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients in UK hospitals. The Company's products are the de facto standard for food safety in leading US supermarket chains. PuriCore also offers a breakthrough wound therapy solution to treat chronic and acute wounds including diabetic ulcers and burns. PuriCore has operations in Malvern, Pennsylvania, US, and in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com, which does not form part of this announcement.

Defined terms in this announcement have the same meaning as set out in the announcement issued by the Company on 19 December 2012.

Enquiries:

 
 UK                          US 
 FTI Consulting              Sage Strategic Marketing 
 Susan Stuart/Simon          Jennifer Guinan 
  Conway 
 Victoria Foster Mitchell    +1 610 410 8111 
 +44 (0) 20 7831 3113 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROMFMGMMVGKGFZM

Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024

Realm Thera. (LSE:RLM)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024